Please assess the completion status of the following clinical trial:

Trial Title: BRIDGE Device for Post-operative Pain Control

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Inclusion criteria:~  * ≥18 years of age but \<70 years of age~ * Actively listed for isolated liver transplantation~ * Subject or legally authorized representative able to sign informed consent~ * Not currently treated with opioids or any medications that may interact with opioids~ * English speaking~ * Willing and able to participate and consent to this study~Exclusion Criteria:~* Diagnosis of acute liver failure or primary sclerosing cholangitis (PSC)~* Anticipated that the subject will require a new roux-en-y hepaticojejunostomy~* Current use of opioid use or other substance abuse.~* Chronic pain disorders~* Need for regional anesthesia (regional nerve blocks or epidurals)~* Adhesive allergy/sensitivity~* Subject admitted to the ICU at the time of transplant

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- Group 1 (Type: EXPERIMENTAL): BRIDGE device will be placed prior to start of the surgery with standard of care pain control analgesia
- Group 2 (Type: NO_INTERVENTION): Subjects will receive the standard of care pain control analgesia

Based on this trial design, predict the completion outcome and termination type (if applicable).